Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Stromal Tumors × Axitinib × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 21 Neoplasms 7 Kidney Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Carcinoma 5 Melanoma 4 Lung Neoplasms 4 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Kidney Diseases 2 Clear-cell metastatic renal cell carcinoma 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1

Interventions

Sunitinib 14 Imatinib Mesylate 12 nilotinib 7 ripretinib 3 regorafenib 3 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 3 pexidartinib 2 pembrolizumab 2 avapritinib 2 Bevacizumab 2 trametinib 1 spartalizumab 1 romidepsin 1 ponatinib 1 pazopanib 1 palbociclib 1 olaratumab 1 guadecitabine 1 ferric carboxymaltose 1 epacadostat 1 dabrafenib 1 cediranib 1 Surveys and Questionnaires 1 Sorafenib 1 Observation 1 Iron-Dextran Complex 1 Indocyanine Green 1 Immunoglobulin G 1 HhAntag691 1 Fluorescein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡